Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin

Acarix AB (publ) (“Acarix” or the “Company”) today announced that a private cardiology clinic in Berlin headed by Dr. med. Niels Jacobsohn has placed the first order in the important German market for its CADScor®System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD). A recently presented study at the American College of Cardiology (ACC) 2017 Annual Scientific Meeting showed that CADScor®System rules out CAD with 97% negative predictive value. The German order follows a placement in a key Danish hospital setting.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.